UP Matrix ScorecardLast updated: April 2026

HealthLearn

HealthLearn's intervention is fundamentally unproven, with mixed results on behavior chage during the pilot. However, its scalability and ability to be a 'turnkey' solution, alongside its commercial revenue stream, make it an exciting-but-risky bet. We think an RCT of their work is a priority, to establish its ability to change behaviours and health coutcomes on the frontline.

Overall Rating
Cost Effectiveness Rating
Cost Effectiveness Rationale>20xGiveWell Benchmark
Our RecommendationCautious Buy

Key Information

Overview

HealthLearn offers mobile-friendly, accredited, case-based online training for health workers, to get them to implement effective, cheap interventions in their practice.

RegistrationUS
Turnover (USD)$548k
StageEarly mid-stage
Countries ActiveNigeria, Zambia, Uganda
54321Intervention Evidence QualityOrganisation Evidence QualityPotential for ScalePayer-at-scale InterestFit for Global Health Fund
The UP Index™2.4 / 5

Pathways to Scale

Payer-at-scale Interest
Government Adoption
Franchise/Replication (by other NGOs)
Commercial Revenue

Impact Metrics

Death prevented (per $1M at scale)363
ConfidenceLow
Cost per DALY averted$6-$43
Total annual reach50,000 community health workers trained

International Evidence

Intervention Evidence QualityRationale: Few/no RCTs of this specific behaviour change model
Low
Quasi-Experimentalyes
Single RCTno
Multiple RCTsno
Meta-Analysisno

Implementation Evidence

Organisation / Programme Evidence QualityRationale: Limited pilot with mixed results
Low
Pilot Studyyes
Quasi-Experimentalno
Single RCTno
Multiple RCTsno
↓ Download PDF